This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kenneth P. Johnson, MD; San Francisco

Arch Neurol. 1980;37(9):535-536.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Multiple sclerosis (MS), although described more than 100 years ago, remains an etiologic and therapeutic enigma despite massive research attention stimulated in large part by the National Multiple Sclerosis Society. In view of the effort invested in studies of MS, relatively few repeatedly confirmed facts are known about the disease. The variable clinical pattern, with remitting disease in young adult life and progressive disease later on, is well known; and there is little doubt that it is a disease found primarily in temperate areas of the world, occurring more commonly in white patients and in women. Epidemiologic and tissue antigen studies strongly suggest that MS has a genetic component.¹ Nevertheless studies of migrating populations also strongly suggest an environmental factor,² and even the likelihood that MS may occur in epidemic form.³

Pathologically, the primary destruction of CNS myelin in focal plaques is universally appreciated; however, less is . . . [Full Text PDF of this Article]

Author Affiliations
Department of Neurology Veterans Administration Medical Center 4150 Clement St

CA 94121

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?